Key outcomes: Mean weight loss: 14.9% (vs 2.4% placebo) 86.4% of participants achieved 5% loss (vs 31.5% placebo) 50.5% achieved 15% loss (vs 4.9% placebo) SELECT (Lincoff et al., NEJM 2023) added the cardiovascular signature: in 17,604 non-diabetic adults with prior CV history, semaglutide 2.4 mg reduced MACE (CV death, MI, stroke) by 20% over 3 years
Please talk with your doctor about the risks and side effects before starting any GLP-1 medication
Without containing any real GLP-1 or GLP-1 receptor agonist , these patches cannot mimic the appetite suppression or weight loss often achieved through prescription medications
Many of our treatments are focused on improving your body muscles, stamina, and strength
If qualified, were able to prescribe GLP-1 weight loss medications for as little as $40/per week
What Is GLP-1 GLP-1, or glucagon-like peptide-1 , is a hormone released in the gut after eating